Infectious Disease

Oragenics secures CQDM funding for Covid-19 vaccine antigen development

Oragenics has secured funding from the Canadian bioresearch consortium CQDM to develop a variant-agnostic protein antigen for use in its…

Pneumagen raises £8 million for further study of intranasal antiviral

Pneumagen has raised £8m ($10 million) for the further development of its intranasal antiviral drug neumifil in Phase II studies…

SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine

SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine,…

Valneva seeks Health Canada approval for chikungunya vaccine

Valneva has submitted a regulatory application to Health Canada, seeking marketing approval for its chikungunya vaccine candidate, VLA1553. The vaccine…

Roche Canada and pCPA conclude talks for Vabysmo eye therapy

Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection). Vabysmo is administered into…

Meningitis vaccine comes to the forefront with impressive study results

A new vaccine developed by the Serum Institute of India to fight meningococcal disease could help eliminate meningitis across Africa.…

Clover collaborates with Kyuan Trade to launch AdimFlu-S (QIS) in China

Clover Biopharmaceuticals has established a commercial collaboration with Keyuan Xinhai (Beijing) Medical Products Trading (Kyuan Trade) for the launch of…

FDA approves breakthrough pneumonia therapy

Innoviva has snagged a win for its bacterial pneumonia drug Xacduro (durlobactam sodium + sulbactam) with a US Food and…

Croda Pharma and BSI partner for vaccine adjuvant QS-21 production

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade…

Parliamentarians call on G7 leaders to invest in neglected tropical diseases

Parliamentarians from 24 countries worldwide have called for a renewed commitment and increased investment for neglected tropical diseases or NTDs,…